Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Dose-Escalation Study of AND017 in Healthy Subjects
NCT04751539Phase 1Completed
- Sponsor
- Kind Pharmaceuticals LLC
- Start
- Jul 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of AND017 in anemia (3 arms), sponsored by Kind Pharmaceuticals LLC. Primary endpoint: Safety evaluations at 17 Days. Started Jul 2018; status: completed.
02
Drugs
AND017
03
Conditions
anemia
Beyond the preview
Go deeper on NCT04751539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04751539.